Physician profile
Glenn E Merz
NPI 1003819400
$968.45
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $792 · 2020: $177.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $195.00 | 2019-2020 | |
| Pfizer INC. | $184.20 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $111.22 | 2019 | |
| Amgen INC. | $92.84 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $60.11 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.66 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.72 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $32.63 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $32.37 | 2019 | |
| Astellas Pharma US INC | $20.26 | 2019 | |
| Si-Bone, INC. | $16.73 | 2019 | |
| Allergan, INC. | $16.60 | 2020 | |
| Amarin Pharma, INC. | $16.38 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.74 | 2019 | |
| Endo Pharmaceuticals INC. | $14.40 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $14.34 | 2019 | |
| Radius Health, INC. | $14.32 | 2020 | |
| Glaxosmithkline, LLC. | $13.90 | 2019 | |
| Lilly USA, LLC | $13.59 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.11 | 2019 | |
| Tris Pharma INC | $11.33 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Merz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.